Navigation Links
Para 5X Whole Blood Hematology Control, Five-part Differential

ProductsPara 5X Whole Blood Hematology Control, Five-part Differential
Company Streck
Item Para 5X Whole Blood Hematology Control, Five-part Differential
Features 
Description Para 5X is a whole blood hematology control manufactured specifically for the ABX Pentra 60C+, 80 and 120, and the Coulter AcT5diff instruments. The composition of this product offers a unique white cell differential, positioning the populations within the limitations of the algorithms on the systems. The product offers 105-day closed-vial stability and 14-day open-vial stability. Para 5X is packaged in a 3.0ml pierceable cap vial compatible with closed-tube sampling systems.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. Series 590 Low Cost Whole Blood Aggregometers
2. ACCUTEST Mononucleosis Whole Blood Test
3. ACCUTEST H. pylori Test (Whole Blood)
4. SST-1 Whole-field Scotopic Sensitivity Tester
5. Liquichek Whole Blood Volatiles Control
6. Lyphochek Whole Blood Control
7. Lyphochek Whole Blood Metals Control
8. Model 700 Whole Blood/Optical Lumi-Aggregometer
9. Glass Whole Blood Tube with K3EDTA
10. Whole Body Hypothermia System
11. Malaria (P. Falciparum) Whole Blood Strip / Cassette
... Celluthin effectively delivers clinically proven aminophylline directly ... reduction. Topical fat reduction with the aminophylline ... fat and an increase in the firmness ... deep into the skin where it causes ...
... Contour is a non-invasive massage machine ... and the circulatory system. Extraordinary results ... Directional-Stroking action, which combines vertical and ... comfortable percussion, gyratory massage, deep tissue ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
Medicine Products:
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ... pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, ... , Dr. Olson says the decision to support the pageant in an official ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Today, ... optimize the ingestion of their medication by matching users with high quality water pipes ... compare pieces with no commitment. , Inhale was founded by two brothers, Nick and ...
(Date:6/23/2016)... ... June 23, 2016 , ... An article published June 8 ... between head and neck cancer in individuals with unhealthy oral hygiene habits. The article ... on whether they had gum disease, brushed their teeth on a daily basis, wore ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: